InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
64,272.14
(
0.59%
)
Post# of 97237
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

BioHunter

Send PM Follow Ignore
Followers 246
Posts 636
Boards Moderated 1
Alias Born 04/20/2007

BioHunter

Re: None

Thursday, 04/28/2016 7:05:38 AM

Thursday, April 28, 2016 7:05:38 AM

Post# of 97237
$ADMS Adamas Announces Positive Top-line Results from its Phase 3 EASE LID 3 Trial of ADS-5102 for the Treatment of Levodopa-induced Dyskinesia (LID) in Patients with Parkinson’s Disease

http://finance.yahoo.com/news/adamas-announces-positive-top-line-110000592.html

-BioHunter

-BioHunter
Twitter: @TheBio_Hunter

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up